Skip to main content

ORIGINAL RESEARCH article

Front. Mol. Biosci.
Sec. Molecular Diagnostics and Therapeutics
Volume 11 - 2024 | doi: 10.3389/fmolb.2024.1390079

Longitudinal evaluation of laboratory results and method precision in worldwide erythropoietin external quality assessments Provisionally Accepted

 Luisa Toll1, 2*  Nathalie Weiss3  Laura Vierbaum3 Ingo Schellenberg3, 4  Mario Thevis2 Folker Wenzel1, 3
  • 1Faculty of Medicine and Life Sciences, Furtwangen University, Germany
  • 2Center for Preventive Doping Research, German Sport University Cologne, Germany
  • 3INSTAND e.V, Germany
  • 4Institute of Bioanalytical Sciences (IBAS), Center of Life Sciences, Anhalt University of Applied Sciences, Germany

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

This study presents a longitudinal analysis of external quality assessment (EQA) results for erythropoietin (EPO) determinations conducted between 2017 and 2022 with a continuously increasing number of participating laboratories throughout the years. The aim of this work was to evaluate participant performance and methodological aspects. In each of the eleven EQA surveys, a blinded sample set of lyophilized human serum containing one sample with lower EPO concentrations (L) and one with higher EPO concentrations (H) was sent to the participating laboratories. A total of 1256 measurements were included. The median (interquartile range) fraction of participants not meeting the criteria of acceptance set at 20 % around the robust mean of the respective survey was 9.5 % (6.1 -10.7 %) (sample L) and 9.1 % (5.8 -11.8 %) (sample H) but without a clear trend in the observed period. Some surveys exhibited unusually high inter-laboratory variation, suggesting interfering components in the EQA samples. Different immunological methods and reagent manufacturers also showed variability in measurement outcomes to some extent. These findings highlight the need for continuous quality assessment in EPO measurements to ensure patient safety and allow identifying areas for further research and investigation. measurement procedures used (Favaloro et al., 2018). External 87 quality assessment (EQA) is frequently used to independently 88 evaluate and compare laboratory performance. 89 hat gelöscht: already 90 hat gelöscht: 6 91 hat gelöscht: independent 92 hat gelöscht: INSTAND e.V. -a scientific medical society 93 supporting the quality assurance in medical laboratories -introduced 94 its first EQA for EPO in 2017. INSTAND is an independent 95 accredited organization performing EQA in laboratory medicine.

Keywords: External quality assessment, Proficiency testing, Erythropoietin, Method precision, Immunoassay

Received: 22 Feb 2024; Accepted: 10 May 2024.

Copyright: © 2024 Toll, Weiss, Vierbaum, Schellenberg, Thevis and Wenzel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mx. Luisa Toll, Faculty of Medicine and Life Sciences, Furtwangen University, Schwenningen, Germany